Genmab reported 514M in EBIT for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Agios Pharmaceuticals AGIO:US $ -104827000 13.68M
AstraZeneca AZN:LN 3.32B 3.32B
Bayer BAYN:GR 3.47B 2.25B
Fresenius Medical Care FME:GR 471M 13M
Galapagos GLPG:NA 10.15M 88.35M
Genmab GEN:DC 514M 295M
GRIFOLS GRF:SM 245.2M 40.86M
Hikma Pharmaceutical HIK:LN 279M 1000K
Immunogen IMGN:US $ -22852000 11.7M
Lonza Group LONN:SW 545M 54M
Novartis NOVN:VX 2.88B 596M
William Demant Holding WDH:DC 1.83B 243M